JAMES H. BRENNAN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Inhibitor Therapeutics, Inc.

Filing Date Source Excerpt
2007-01-08 As of the completion of the Acquisition, CBI's Board of Directors and executive officers will be as follows: James H. Brennan, 54, Vice President - Financial Operations

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-25